Groove Botanicals, Inc. (GRVE)
OTCMKTS · Delayed Price · Currency is USD
0.0040
0.00 (0.00%)
At close: Jun 29, 2026

Groove Botanicals Financials Overview

Millions USD. Fiscal year is Apr - Mar.

Revenue & Profits

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Revenue
------
Revenue Growth
------
Gross Profit
------
Operating Income
-0.14-0.14-0.13-0.27-0.18-0.42
Net Income
-0.36-0.36-0.35-0.42-0.12-0.29
Earnings Per Share
-0.01-0.01-0.01-0.01-0.00-0.01
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Investments
000000.05
Total Debt
----0.090.16
Net Cash (Debt)
0000-0.09-0.12
Net Cash Growth
-26.45%-26.45%20.97%---
Net Cash Per Share
0.000.000.000.00-0.00-0.00

Cash Flow & CapEx

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Cash Flow
-0.09-0.09-0.11-0.09-0.1-0.07
Capital Expenditures
------
Free Cash Flow
-0.09-0.09-0.11-0.09-0.1-0.07
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Gross Margin
------
Operating Margin
------
Profit Margin
------
FCF Margin
------

Valuation

Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingAug '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PS Ratio
------